MARLEN TREVINO: Open Payments
NPI 1679809446 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 48 payments from 10 companies in 2025. Trend: 2023 $630 · 2024 $826 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $278 |
| Abbott Laboratories | 5 | $113 |
| Lilly USA, LLC | 6 | $111 |
| Corcept Therapeutics | 3 | $72 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Optinose US, Inc. | 1 | $26 |
| Evofem Biosciences, Inc. | 3 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Wegovy, FREESTYLE LIBRE 3, MOUNJARO, Korlym, Ozempic, GARDASIL 9, JARDIANCE, Rybelsus.
Industry payments across TX — which companies pay providers there.
